Recent RENB News
- Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs • GlobeNewswire Inc. • 04/22/2025 01:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/18/2025 09:00:41 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/15/2025 01:46:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2025 08:55:50 PM
- Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine • GlobeNewswire Inc. • 04/09/2025 01:25:00 PM
- Renovaro Provides Update to Definitive Agreement with Predictive Oncology • GlobeNewswire Inc. • 04/04/2025 01:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2025 12:12:50 PM
- Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology • GlobeNewswire Inc. • 03/03/2025 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2025 09:05:41 PM
- Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine • GlobeNewswire Inc. • 02/26/2025 06:25:00 PM
- Renovaro Announces $15 million in Equity Committed • GlobeNewswire Inc. • 02/26/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 06:33:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2025 06:29:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/19/2025 09:02:47 PM
- Investors Eye Biotech Sector as Cancer Therapy Market Surges • PR Newswire (US) • 02/19/2025 03:10:00 PM
- Investors Eye Biotech Sector as Cancer Therapy Market Surges • PR Newswire (US) • 02/19/2025 03:06:00 PM
- Investors Eye Biotech Sector as Cancer Therapy Market Surges • PR Newswire (Canada) • 02/19/2025 03:06:00 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 02/19/2025 02:00:38 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/19/2025 01:55:44 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 02/19/2025 01:50:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2025 01:45:21 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/18/2025 09:51:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2025 09:05:12 PM
7.2 MW Glor Rd Solar Project in Development by SolarBank in New York • GY2 • Apr 29, 2025 9:06 AM
Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology • AVAI • Apr 29, 2025 8:00 AM
Cannabix Enters Sales Distribution Agreement with Alco Prevention Canada for BreathLogix Autonomous Alcohol Breathalyzer • BLO • Apr 28, 2025 8:49 AM
Veri Medtech (VRHI) Retains PCAOB Auditor • VRHI • Apr 28, 2025 8:30 AM
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement • COEP • Apr 25, 2025 8:33 AM
UAV Corp. Successfully Completes Inflation Test of DART SA-70 Airship, Paving Way for Flight Readiness • UMAV • Apr 24, 2025 8:30 AM